My recent visit to Zimbabwe

 The journey was well planned and it took us less than 10 hours to reach our destination from Pretoria South Africa to Mvuma central Zimbabwe.  A lot of construction is happening on the roads. Harare to Masvingo Highway is complete and the remaining part which was left between Beitbridge and Masvingo is being completed.  Surely by December it should be done. Though there is a lot of money being miss used, there are elements of success. Harare to Beitbridge road was a death trap, the road had so many potholes, had no shoulder no fencing to protect  animals from entering the road and some parts even worn out that left it narrow in a way that two trucks cannot pass without one having to go out of the road.  Those improvements form part of the new Government's transformation policy. There is job creation and slowly improving the standards which has been declining for more that 20 to 30 years. Surely Rome was not built over night. At the border you can see significan...

CAPE TOWN, Feb 15 (Reuters) - South Africa's drugs regulator SAHPRA said on Monday it has approved an implementation study of Johnson & Johnson's COVID-19 vaccine, clearing the way to start the country's first inoculations among health workers.

 * Govt still reviewing J&J’s full market application

* Implementation study is to vaccinate health workers
* S.Africa expected to receive J&J’s vaccines this week (Adds detail, quotes)

By Wendell Roelf

South Africa is yet to start its COVID-19 vaccination programme and the government has decided to go with the J&J dose after trial results this month showed AstraZeneca’s two-shot vaccine was less effective against the new variant of the coronavirus dominating South African infections.

“SAHPRA has approved the implementation study,” the regulator said in response to Reuters questions, but added it was still reviewing its separate full market application.

The implementation study, similar to the final phase of a vaccine trial, will test the effects of the vaccine in the field after it is administered to around 350,000 to 500,000 health care workers.

The first batch of J&J’s 80,000 doses are expected to arrive this week, President Cyril Ramaphosa told lawmakers on Thursday.

J&J was the first pharmaceutical major to apply to the local regulator in December to register its COVID-19 vaccine, although Pfizer and AstraZeneca have also applied.

South Africa is currently the hardest hit African country and accounts for over a third of the continent’s infections and almost half of the deaths, led primarily by the new, more contagious variant called 501Y.V2.

The South African Health Products Regulatory Authority (SAHPRA) said J&J has not yet submitted a special domestic application for emergency use authorisation of its vaccine – known as a Section 21 application.

Normally valid for six months, Section 21 authorisation allows emergency use of a product that is unregistered, SAHPRA officials said.

However, J&J’s application for full market registration was being processed as part of a rolling review approach, which allows data to be evaluated by SAHPRA as it becomes available, the regulator said. “The rolling review has received its second batch of data and is under review. The full process is estimated to be complete after four batches of rolling data (are received),” said SAHPRA.

This is one of several methods the domestic regulator is pursuing to help fast-track vaccine approvals. (Reporting by Wendell Roelf; editing by Promit Mukherjee and Jason Neely)

Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email letters@dailymaverick.co.za

 

Comments

Popular posts from this blog

MultiChoice’s BEE scheme trying to find 22 000 shareholders who are missing out on millions

Which countries have the world’s largest coal reserves?

This New Ultralight Aircraft May Be World’s Fastest Single-Engine Business Jet